The Use of Methylsulfonylmethane‐Containing Products in Dermatology: An Evidence‐Based Systematic Review of Safety and Efficacy
Authors:
- Nana-Hawwa Abdul-RahmanNANana-Hawwa Abdul-Rahman
- Lucie JoergLJLucie Joerg
- Jacqueline D. WangJWJacqueline D. Wang
- Sonal ChoudharySCSonal Choudhary
Open Access
- 1 January 2026
- journal article
- review article
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Abstract
Background: Methylsulfonylmethane (MSM) is a biologically active sulfur compound that has been implicated in structural protein synthesis and anti‐inflammatory signaling pathways. We conducted a systematic review to evaluate the efficacy and safety of MSM in skin care products and explore the underlying mechanism of action. Methods: This review followed PRISMA guidelines and was registered on PROSPERO (CRD420251274679). PubMed, Embase, ClinicalTrials.gov, Cochrane Library, and Ovid/MEDLINE were searched from inception through December 23, 2025. Eligible studies evaluated topical or oral MSM for dermatologic conditions in human participants. Risk of bias was assessed using the Cochrane Risk of Bias 2.0 tool for randomized control trials and the Newcastle–Ottawa Scale for nonrandomized studies. Results: Of the 228 records identified, seven studies ( n = 416) met the inclusion criteria: six randomized controlled trials and one case report, in adults with acne vulgaris, erythematous‐telangiectatic rosacea, nail psoriasis, skin aging, and X‐linked ichthyosis. MSM‐containing interventions (both topical and oral) were associated with statistically significant improvements in clinical severity and skin‐related outcomes, including inflammatory lesion counts, erythema, nail severity scores, and measures of skin hydration, elasticity, firmness, texture, and dermal thickness. Reported adverse events were mild and transient, with no serious adverse events or treatment‐related withdrawals. Conclusions: The most reliable evidence supports oral MSM for photoaging, moderate support for acne, erythematous‐telangiectatic rosacea, and nail psoriasis, and weakest evidence for X‐linked ichthyosis. Importantly, studies lasting up to 24 weeks did not identify any serious safety concerns.Keywords
This publication has 25 references indexed in Scilit:
- The effect of a 12-week dietary intake of food supplements containing collagen and MSM on dermis density and other skin parameters: A double-blind, placebo-controlled, randomised four-way study comparing the efficacy of three test productsJournal of Functional Foods, 2023
- Dimethyl sulfoxide (DMSO): a solvent that may solve selected cutaneous clinical challengesArchives of Dermatological Research, 2022
- Beauty from within: Oral administration of a sulfur-containing supplement methylsulfonylmethane improves signs of skin ageingInternational Journal for Vitamin and Nutrition Research, 2022
- Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicinCell Biology and Toxicology, 2020
- Methylsulfonylmethane inhibits NLRP3 inflammasome activationCytokine, 2015
- Effect of Methylsulfonylmethane on Paraquat-Induced Acute Lung and Liver Injury in MiceInflammation, 2013
- Cytotoxicity of Methylsulfonylmethane on Gastrointestinal (AGS, HepG2, and KEYSE-30) Cancer Cell LinesJournal of Gastrointestinal Cancer, 2011
- Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritisOsteoarthritis and Cartilage, 2008
- Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trialOsteoarthritis and Cartilage, 2006
- STUDIES ON THE ABSORPTION, EXCRETION AND METABOLISM OF DIMETHYLSULFOXIDE (DMSO) IN MANThe Journal of Pharmacology and Experimental Therapeutics, 1967